Vol 3 (January 2019): Biotarget

Editorial

What’s up with MALAT1?

Gary A. Clawson

Biotarget

2019;

3:

3

.

(25 January 2019)

PDF Full Text (1861) COI Form Open Access

Editorial

The new role of lncRNA MALAT1 as a tumor suppressor

Manuel Regouc, Martin Pichler

Biotarget

2019;

3:

2

.

(23 January 2019)

PDF Full Text (1864) COI Form Open Access

Editorial

Engineered natural killer cells expressing chimeric antigen receptors (CAR)—a promising approach in tumor immunotherapy

Brigitte Neuber, Michael Schmitt

Biotarget

2019;

3:

1

.

(09 January 2019)

PDF Full Text (2570) COI Form Open Access